Is midaz contraindicated in asthma

Reading Document
Medical Text Search

midazolam contraindications asthma respiratory

Medical Text Search

benzodiazepine sedation bronchospasm airway hyperreactivity

GradeResponse
GradeResponse
Midazolam (midaz) is NOT contraindicated in asthma.
Here is a breakdown of the key points:

Contraindications to Midazolam

The actual contraindications to midazolam include:
  • Known hypersensitivity to benzodiazepines
  • Acute narrow-angle glaucoma
  • Severe hepatic impairment (relative)
  • Shock or hemodynamic instability (caution)
  • Concurrent use of strong CYP3A4 inhibitors (relative)

Midazolam in Asthma — Is it Safe?

Asthma is not a contraindication. In fact, midazolam has properties that can be beneficial in the asthmatic patient:
PropertyRelevance to Asthma
AnxiolysisReduces anxiety-driven tachypnea and work of breathing
BronchoneutralDoes not cause bronchospasm (unlike some opioids that can release histamine)
Muscle relaxationCan reduce accessory muscle fatigue

Key Caution: Respiratory Depression

The main concern with midazolam in any patient with reactive airway disease is respiratory depression, not bronchospasm. This is particularly relevant when:
  • Used in high doses for procedural sedation
  • Combined with opioids (synergistic respiratory depression)
  • Patient has severe acute asthma with already-compromised respiratory reserve
Per status epilepticus guidelines, respiratory depression is the most clinically significant adverse event with benzodiazepines, though rates in children tend to be lower than in adults.

Contrast with Drugs That ARE Cautioned in Asthma

  • NSAIDs/aspirin — can trigger aspirin-exacerbated respiratory disease
  • Beta-blockers — can cause bronchoconstriction
  • Morphine — histamine release may worsen bronchospasm
  • Neostigmine — cholinergic, can increase airway secretions and bronchospasm
  • Thiopental — more bronchospasm risk than midazolam for induction

Bottom Line

Midazolam can be used in asthmatic patients. Monitor for respiratory depression, especially in acute severe asthma where the respiratory drive is already stressed. It is often a preferred agent for procedural sedation and RSI premedication because it lacks the bronchospasm-triggering properties of some alternatives.
This is a shared conversation. Sign in to Orris to start your own chat.